Skip to main content
OSTEOPORE LIMITED logo

OSTEOPORE LIMITED — Investor Relations & Filings

Ticker · OSX ISIN · AU0000053324 ASX Manufacturing
Open in API
Filings indexed 488 across all filing types
Latest filing 2024-08-29 Interim / Quarterly Rep…
Country AU Australia
Listing ASX OSX

About OSTEOPORE LIMITED

https://osteopore.com

Osteopore Limited specializes in the design and manufacture of 3D-printed bioresorbable implants. The company utilizes a patented 3D printing process to create scaffolds from bioresorbable polymers, such as polycaprolactone, designed to mimic the natural microstructure of bone. These implants, including the Osteoplug, Osteomesh, and Osteostrip product lines, are applied in neurosurgical, craniofacial, and orthopedic procedures to facilitate bone healing and tissue regeneration. The scaffolds provide a temporary structural framework that supports the body's natural healing process before being gradually absorbed and replaced by the patient's own bone tissue. This technology aims to reduce long-term complications associated with permanent foreign implants by promoting natural tissue integration and restoration across various clinical applications.

Recent filings

Filing Released Lang Actions
Half Yearly Report and Accounts 28 pages 1.2MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Osteopore Limited and its Controlled Entities Appendix 4D' and includes detailed financial data for the half-year ended 30 June 2024. It contains comprehensive financial statements such as the consolidated statement of profit or loss, statement of financial position, cash flows, and notes to the financial statements. The presence of a Directors' Report, Auditor's Independence Declaration, and an Independent Auditor's Review Report further confirms this is a formal financial report. The reporting period is explicitly stated as a half-year, and the document includes substantive financial data and analysis, not just an announcement or summary. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-29 English
OSX and University of Chile complete bone implant studies 3 pages 412.1KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 22 August 2024 about Osteopore Limited completing pre-clinical bone implant studies in partnership with the University of Chile. It discusses the progress of research, funding secured, and future plans for clinical studies. The content is a corporate announcement about research and development progress and partnership updates, not a financial report, earnings release, or regulatory filing. It does not contain financial statements or detailed financial data. The document is relatively short (5629 characters) and serves as a news update to investors and the market. Therefore, it fits best into the category of a Regulatory Filing (RNS), which is a general regulatory announcement or compliance document that does not fit into other specific categories.
2024-08-21 English
Activities Update Qtr Ending June 2024 and Appendix 4C 18 pages 16.3MB
Interim / Quarterly Report Classification · 95% confidence The document contains detailed quarterly financial and operational information for Osteopore Limited for the quarter ending 30 June 2024. It includes revenue growth highlights, clinical trial updates, partnership announcements, and a detailed Appendix 4C Quarterly Cash Flow Report as required by ASX Listing Rule 4.7B. The presence of actual financial data such as cash flows from operating, investing, and financing activities, as well as management commentary on business performance and capital raising activities, indicates this is a comprehensive quarterly financial report. The document is approximately 15,000 characters long, which supports it being a full report rather than a brief announcement. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q2 2024
2024-07-30 English
Application for quotation of securities - OSX 6 pages 18.2KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and is an announcement from Osteopore Limited regarding the application for quotation of securities on the ASX. It details the number and type of securities to be quoted, issue dates, and other related information about securities issued due to options being exercised or convertible securities converted. This is a formal application for listing new securities on the exchange, which corresponds to announcements about share issues or capital changes. The document is not a financial report, earnings release, or management discussion, but rather a regulatory announcement about securities quotation. Therefore, the appropriate classification is 'Share Issue/Capital Change' (SHA). The document length and content confirm it is not a brief report publication announcement or a certification, but a substantive announcement of capital change.
2024-07-30 English
Ceasing to be a substantial holder 3 pages 1.6MB
Regulatory Filings
2024-07-25 English
Application for quotation of securities - OSX 6 pages 18.2KB
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 2A form, which is a standard ASX (Australian Securities Exchange) announcement used to apply for quotation of securities. It details the issuance and quotation of new securities resulting from options being exercised or convertible securities being converted. The document includes specifics such as the number of securities, issue date, issue price, and the resulting issued capital. It is not a financial report, earnings release, or management discussion, but rather a formal announcement related to capital changes and securities quotation. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is the announcement itself, not a report publication or regulatory filing.
2024-07-16 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.